Sigma-Tau Pharmaceuticals, Inc. insider trades: Soligenix (SNGX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Sigma-Tau Pharmaceuticals, Inc. reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 29, 2017 | SNGX | ↓ Sell | 293,510 | $2.12 | $622K | Indirect | Dec 1, 2017 (2d) |
| Nov 29, 2017 | SNGX | ↑ Buy | 293,510 | $2.12 | $622K | Direct | Dec 1, 2017 (2d) |
| Jun 18, 2010 | SNGX | ↑ Buy | 8,608,580 | $0.20 | $1.8M | Indirect | Jun 21, 2010 (3d) |
| Sep 24, 2009 | DORB | ↑ Buy | 3,952,569 | $0.25 | $1000K | Indirect | Sep 28, 2009 (4d) |
| Feb 11, 2009 | DORB | ↑ Buy | 25,000,000 | $0.18 | $4.5M | Indirect | Feb 13, 2009 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Sigma-Tau Pharmaceuticals, Inc.'s insider trades
Sigma-Tau Pharmaceuticals, Inc. is an insider at Soligenix (SNGX). Since Feb 11, 2009, it has reported 4 open-market purchases worth $7.9M and 1 sale worth $622K on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNGX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.